Contrarily, the negative association between ESRP1 expression and patient survival as well as the pro-tumorigenic role of ESRP1 have been reported in some cancers, such as breast and ovarian cancers (Tables 1 and 2). The gene discussed is ESRP1; the disease is ovarian cancer.